Biomarker Screening for Lung Cancer
Lung Cancer Biomarkers and Screening
- Age
- 50 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 3,606 (estimated)
- Sponsor
- NYU Langone Health · Other
This trial is looking for people to help study tests that use biomarkers to find lung cancer early. Participants will either be at high or low risk for lung cancer or have suspicious lung nodules needing evaluation.
You may be able to join if
- I am at high- or low-risk for lung cancer
- I have a smoking history of 20 pack years or more
- I am 50 years or older with less than 20 pack years of smoking
- I have been referred for evaluation of suspicious lung nodules
You may not be able to join if
- I am pregnant
- I have a prior cancer other than nonmelanoma skin cancer
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityRATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.
Loading trial locations…